skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Principles in genetic risk assessment || FREE PAPER ||

(3134) Views  (564) Full article downloads

Authors: Pedro Viana Baptista

Published Date January 2005 Volume 2005:1(1) Pages 15 - 20
DOI: http://dx.doi.org/10.2147/TCRM.S

Pedro Viana Baptista

Centro de Investigação em Genética, Molecular Humana, Secção Autónoma de Biotecnologia, Faculdade de Ciências e Tecnologia – Universidade Nova de Lisboa, Caparica, Portugal

Abstract: Risk assessment constitutes an essential component of genetic counseling and testing, and the genetic risk should be estimated as accurately as possible for individual and family decision making. All relevant information retrieved from population studies and pedigree and genetic testing enhances the accuracy of the assessment of an individual’s genetic risk. This review will focus on the following general aspects implicated in risk assessment: the increasing genetic information regarding disease; complex traits versus Mendelian disorders; and the influence of the environment and disease susceptibility. The influence of these factors on risk assessment will be discussed.


Keywords: genetics, risk assessment, genetic testing, genetic risk, genetic susceptibility

 








Readers of this article also read:

Oral paricalcitol for the treatment of secondary hyperparathyroidism in chronic kidney disease
Effectiveness of lifestyle measures in the treatment of gastroesophageal reflux disease – a case series
Brimonidine in the treatment of glaucoma and ocular hypertension
In vitro fertilization (IVF): a review of 3 decades of clinical innovation and technologic advancement
Abatacept in the treatment of rheumatoid arthritis
Azacytidine (Vidaza®) in the treatment of myelodysplastic syndromes
Towards a new standard of perioperative fluid management
In-hospital resuscitation: opioids and other factors influencing survival
Classification and management of mild head trauma
Demonstration of an online tool to assist managed care formulary evidence-based decision making: meta-analysis of topical prostaglandin analog efficacy